Direct pathogen detection from swab samples using a new high-throughput sequencing technology.
The detection of emerging infectious diseases has been a continuing concern, especially with the novel influenza A (H1N1) viral pandemic of 2009. In the present study, we validated a 'second-generation' parallel sequencing platform for viral detection in swab samples collected during recent influenza virus infections in Beijing. This operation yielded millions of valid reads per sample and resulted in an almost complete spectrum of nucleotide information. Importantly, novel A (H1N1) and seasonal A (H3N2) influenza virus-derived sequences were detected without prior knowledge or use of genetic information in advance, suggesting that this approach could be a valuable tool for diagnosing emerging infectious diseases.
Yongfeng
H
H
State Key Laboratory for Molecular Virology and Genetic Engineering, Institute of Pathogen Biology, Chinese Academy of Medical Sciences, Beijing, China.
Fan
Y
Y
Jie
D
D
Jian
Y
Y
Ting
Z
Z
Lilian
S
S
Jin
Q
Q
D021821:Communicable Diseases, Emerging / Q000175:diagnosis / Q000821:virology; D057166:High-Throughput Screening Assays / Q000379:methods*; D006801:Humans; D009980:Influenza A virus / Q000235:genetics* / Q000302:isolation & purification*; D007251:Influenza, Human / Q000175:diagnosis* / Q000821:virology*; D014773:Virology / Q000379:methods*
Clin Infect Dis. 2009 Nov 15;49(10):1622-3
19857173
Clin Microbiol Infect. 2004 Oct;10(10):865-7
15373878
Nucleic Acids Res. 2007 Jan;35(Database issue):D61-5
17130148
Clin Microbiol Rev. 2008 Oct;21(4):716-47
18854489
Clin Microbiol Infect. 2009 Dec;15(12):1146-53
19456830
PLoS One. 2009;4(1):e4219
19156205
Genome Res. 2008 Nov;18(11):1851-8
18714091